相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
常温,避光
- 克隆性:
单克隆
- 抗体名:
Influenza B Hemagglutinin / HA抗体
免疫原 :
Recombinant Influenza B virus HA protein ( Catalog#11053-V08H )
Antibody Type : Rabbit Monoclonal Antibody ( Rabbit mAb Service Platform )
克隆号 :
004
抗体宿主 :
Rabbit IgG
缓冲液 : 0.2 μm filtered solution in PBS, 5% trehalose may be added in some batches. Please read the hardcopy of COA or contact our customer service to confirm the formulation.
制备方法 :
This antibody was obtained from a rabbit immunized with purified, human cell-derived, recombinant Influenza B Hemagglutinin ( rvHA ; Catalog#11053-V08H ; ACA33493.1 ; Met 1 - Ala 555 )
Influenza B Hemagglutinin / HA抗体Background
Influenza (flu) is a respiratory infection in mammals and birds. This virus is divided into three main types (A, B and C). Influenza A is found in a wide variety of bird and mammal species. Influenza B is largely confined to humans and is an important cause of morbidity. Influenza C infects humans, dogs and pigs, sometimes causing both severe illness and local epidemics. Influenza A is further divided into subtypes based on differences in the membrane proteins hemagglutinin (HA) and neuraminidase (NA). The notation HhNn is used to refer to the subtype comprising the hth discovered HA protein and the nth discovered NA protein. The HA is a trimer with a receptor binding pocket on the globular head of each monomer. Subtypes are further divided into strains. Each genetically distinct virus isolate is usually considered to be a separate strain. Influenza B viruses are only known to infect humans and seals, giving them influenza. This limited host range is apparently responsible for the lack of Influenza virus B caused influenza pandemics in contrast with those caused by the morphologically similar Influenza virus A as both mutate by both genetic drift and reassortment. Influenza B viruses evolve slower than A viruses and faster than C viruses. Influenza B virus mutates at a rate 2 to 3 times lower than type A. However, influenza B mutates enough that lasting immunity is not possible.
Influenza B Hemagglutinin / HA抗体相关产品如下:
hz-0396R VCAM-1血管内皮细胞粘附分子抗体
hz-13854R Valine缬氨酸抗体
hz-10529R VAP1血管粘附蛋白1抗体
hz-13741R Vinexin细胞间粘附蛋白Vinexin抗体
hz-8533R Vimentin波形蛋白抗体
hz-13855R Vitamin A维生素A抗体
hz-2533R Versican蛋白聚糖Versican抗体
hz-2169R VWCEVWCE抗体
hz-11496R VAX1视神经视网膜相关蛋白VAX1抗体
hz-11497R VAX2视神经视网膜相关蛋白VAX2抗体
hz-2987R Vitamin D Receptor/VDR维生素D3受体抗体
hz-12326R VPREB1B淋巴细胞前体蛋白1抗体
hz-8994R VCAM-1血管内皮细胞粘附分子抗体
hz-12340R VNN2血管非炎性蛋白2抗体
hz-7883R VHLH脑视网膜血管瘤G7蛋白抗体(逢希伯-林道氏病)
hz-11167R VGLUT1/BNP1脑特异性钠依赖无机磷转运蛋白抗体
hz-9565R VMAT2脑单胺类神经递质转运蛋白抗体
hz-1367R VHL脑视网膜血管瘤G7蛋白抗体(逢希伯-林道氏病)
hz-9465R VANGL2神经管畸形相关蛋白VANGL2抗体
hz-3466R Phospho-VASP(Ser239)磷酸化血管扩张刺激磷蛋白抗体
hz-3467R phospho-VEGF receptor 2 (Tyr1059)磷酸化血管内皮生长因子受体2抗体
hz-0926R V.cholera Ogawa01群小川型霍乱弧菌抗体
hz-10427R VAMP-1+2+3囊泡相关膜蛋白1,2,3抗体
hz-10332R VGF/NERP2神经内分泌调节肽VGF抗体
hz-2309R VP2重组猪细小病毒VP2蛋白抗体
hz-2742R VEGF-D血管内皮生长因子D型抗体
hz-2806R VDCC-L alphaL-型电压依赖型钙通道α抗体
hz-10271R phospho-VAV3(Tyr141)磷酸化鸟嘌呤核苷酸交换因子VAV3抗体
hz-4226R VAPA囊泡相关膜蛋白相关蛋白A抗体
hz-6160R VAV2癌基因VAV2抗体
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验PCR for the Detection of Influenza Viruses in Clinical Material
Influenza viruses are segmented, negative-stranded RNA viruses belonging to the family Orthomyxoviridae . They are classified into influenza A, B, and C on the basis of different epitopes on the nucleoprotein (NP) and matrix proteins (M
Genetic Engineering of Live Attenuated Influenza Viruses
The first live attenuated influenza vaccine (LAIV) was licensed in the USA in 2003; it is a trivalent vaccine composed of two type A (H1N1 and H3N2) and one type B influenza virus each at 107 fluorescent focus units (FFU). Each influenza
Optimizing Particle-Mediated Epidermal Delivery of an Influenza DNA Vaccine in Ferrets
to the model antigens influenza virus hemagglutinin and hepatitis B core antigen. Results from these studies support the use of the PowderJect XR1 device in ferrets for the study of prophylactic and therapeutic DNA vaccines against clinically important diseases
技术资料暂无技术资料 索取技术资料




